Literature DB >> 23836301

[Treatability of sporadic late onset nemaline myopathy].

F Hanisch1, I Schneider, T Müller, B F Romeike, G Stoltenburg, H J Holzhausen, S Zierz.   

Abstract

Sporadic late onset nemaline myopathy (SLONM) is an extremely rare disorder which can be associated with monoclonal gammopathy of unclear significance (MGUS). Clinically SLONM appears mostly after the fourth decade of life as rapidly progressing tetraparesis, respiratory insufficiency and features, such as dropped head syndrome, facial and bulbar involvement. Diagnosis is confirmed by muscle biopsy with detection of nemaline bodies and also frequently lobulated fibres. Immunosuppressant and immunomodulating therapies have been shown to be ineffective but clinical improvement accompanied by disappearance of monoclonal gammopathy and even nemaline bodies was reported following autologous stem cell transplantation and chemotherapy with melphalan. This article presents the case of a 53-year-old man with a 4-year history of SLOMN with MGUS in which administration of intravenous immunoglobulin therapy (IVIG) was not successful in reversing gammopathy, histopathological changes or clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836301     DOI: 10.1007/s00115-013-3825-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  28 in total

1.  Adult-onset nemaline myopathy and monoclonal gammopathy: a case report.

Authors:  N Deconinck; E C Laterre; P Y Van den Bergh
Journal:  Acta Neurol Belg       Date:  2000-03       Impact factor: 2.396

2.  Stem cell transplantation in a patient with late-onset nemaline myopathy and gammopathy.

Authors:  O Benveniste; P Laforet; O Dubourg; S Solly; L Musset; S Choquet; N Azar; M Fardeau; S Herson; V Leblond; B Eymard
Journal:  Neurology       Date:  2008-06-18       Impact factor: 9.910

3.  Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy.

Authors:  Margherita Milone; Amiram Katz; Anthony A Amato; Carl A Soderland; Miruna Segarceanu; Nathan P Young; H Royden Jones
Journal:  Muscle Nerve       Date:  2010-02       Impact factor: 3.217

Review 4.  Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Oncology (Williston Park)       Date:  2011-06       Impact factor: 2.990

5.  Sporadic late-onset nemaline myopathy in a patient with primary Sjögren's syndrome.

Authors:  Miki Suzuki; Yuko Shimizu; Megumi Takeuchi; Masaki Kobayashi; Makoto Iwata; Shinichiro Uchiyama
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

Review 6.  Adult-onset nemaline myopathy: a case report and review of the literature.

Authors:  K A Gyure; R A Prayson; M L Estes
Journal:  Arch Pathol Lab Med       Date:  1997-11       Impact factor: 5.534

Review 7.  Nemaline myopathy: a clinical study of 143 cases.

Authors:  M M Ryan; C Schnell; C D Strickland; L K Shield; G Morgan; S T Iannaccone; N G Laing; A H Beggs; K N North
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

8.  High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

Authors:  Arnaud Jaccard; Philippe Moreau; Veronique Leblond; Xavier Leleu; Lotfi Benboubker; Olivier Hermine; Christian Recher; Bouchra Asli; Bruno Lioure; Bruno Royer; Fabrice Jardin; Frank Bridoux; Bernard Grosbois; Jérome Jaubert; Jean-Charles Piette; Pierre Ronco; Fabrice Quet; Michel Cogne; Jean-Paul Fermand
Journal:  N Engl J Med       Date:  2007-09-13       Impact factor: 91.245

9.  Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations.

Authors:  Pankaj B Agrawal; Corinne D Strickland; Charles Midgett; Ana Morales; Daniel E Newburger; Melisa A Poulos; Kinga K Tomczak; Monique M Ryan; Susan T Iannaccone; Tom O Crawford; Nigel G Laing; Alan H Beggs
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

Review 10.  [Adult-onset nemaline myopathy with distal muscle atrophy--case report].

Authors:  Fumitoshi Niwa; Kensuke Shiga; Masashi Kimura; Tatsuyuki Yamaguchi; Masaki Kondo; Masanori Nakagawa
Journal:  Brain Nerve       Date:  2009-06
View more
  5 in total

1.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

Review 2.  Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Authors:  Lukas J Schnitzler; Tobias Schreckenbach; Aleksandra Nadaj-Pakleza; Werner Stenzel; Elisabeth J Rushing; Philip Van Damme; Andreas Ferbert; Susanne Petri; Christian Hartmann; Antje Bornemann; Andreas Meisel; Jens A Petersen; Thomas Tousseyn; Dietmar R Thal; Jens Reimann; Peter De Jonghe; Jean-Jacques Martin; Peter Y Van den Bergh; Jörg B Schulz; Joachim Weis; Kristl G Claeys
Journal:  Orphanet J Rare Dis       Date:  2017-05-11       Impact factor: 4.123

3.  Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.

Authors:  Rouslan Kotchetkov; Anna Dyszkiewicz-Korpanty; Vishal Kukreti
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

4.  Dropped head syndrome due to neuromuscular disorders: Clinical manifestation and evaluation.

Authors:  Ahmet Z Burakgazi; Perry K Richardson; Mohammad Abu-Rub
Journal:  Neurol Int       Date:  2019-06-19

5.  Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy.

Authors:  Jantima Tanboon; Akinori Uruha; Yukie Arahata; Carsten Dittmayer; Leonille Schweizer; Hans-Hilmar Goebel; Ichizo Nishino; Werner Stenzel
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.